Phase 1 study

Recruiting Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 1
Sponsor ViroMissile, Inc.
Registry number NCT06910657
Started 25 August 2025 Today 16 October 2026 Estimated completion 31 January 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Westmead Hospital Westmead NSW Recruiting
The Alfred Hospital Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 78

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Key Inclusion Criteria:

* Age ≥ 18 years.

* Histologically or cytologically confirmed advanced solid tumors that have progressed despite standard therapy, or for which no standard therapy exists.

* ECOG performance status ≤ 1.

* Measurable disease per RECIST v1.1.

* Adequate organ and bone marrow function.

* At least 28 days since major surgery, prior immunotherapy, or radiotherapy (with exceptions for minor procedures).

* Negative pregnancy test for women of childbearing potential.

* Agreement to use effective contraception during treatment and for 3 months after.

* Ability to provide informed consent and comply with study requirements.

Key Exclusion Criteria:

* Prior treatment with an oncolytic virus.

* Active or recent vaccinia virus infection or smallpox/monkeypox vaccination within 10 years.

* Active uncontrolled infection requiring systemic treatment.

* History of hepatitis B, hepatitis C, or HIV (unless meeting protocol-specific criteria).

* Unresolved ≥ Grade 2 toxicities from prior therapies (except hair loss or stable chronic conditions).

* Active or symptomatic autoimmune disease requiring systemic therapy.

* Active or untreated CNS metastases (unless stable per protocol).

* Significant cardiac disease (e.g., NYHA Class III/IV heart failure).

* Interstitial lung disease or prior pneumonitis requiring steroids.

* Conditions requiring chronic immunosuppressive therapy.

* Severe skin disorders or history of pancreatitis.

* Bleeding disorders or history of recent serious thromboembolic events.

* Any medical or psychiatric condition that could interfere with study participation.

Dates on the record

Started 25 August 2025
Estimated completion 31 January 2027
Registry last updated 5 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 5 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.